PurposeThe Procyrion pump is an intra-aortic ambulatory support device for cardiorenal HF patients refractory to medical management and dependent on hospital care. Procyrion unloads the heart and perfuses the kidneys, improving HF symptoms caused by fluid overload.MethodsUsing an ovine model of chronic HF with decreased EF and an enlarged LV, the Procyrion pump was deployed into the proximal descending aorta. The animal was instrumented to observe ventricular volume and pressure, aortic pressure, renal function, myocardial oxygen extraction, and organ perfusion.ResultsThe Procyrion pump caused significant decreases in afterload and myocardial oxygen consumption as well as increases in cardiac output, ejection fraction, urine output, and glomerular filtration rate. Furthermore, the pump maintained aortic arch pressure and greatly improved myocardial oxygen supply/demand ratio.ConclusionCardiorenal HF patients are in need of treatment options to simultaneously unload the heart and perfuse the kidneys while minimizing coronary and carotid steal. Our data suggest that the Procyrion device meets these needs using an ambulatory, catheter-delivered pump. PurposeThe Procyrion pump is an intra-aortic ambulatory support device for cardiorenal HF patients refractory to medical management and dependent on hospital care. Procyrion unloads the heart and perfuses the kidneys, improving HF symptoms caused by fluid overload. The Procyrion pump is an intra-aortic ambulatory support device for cardiorenal HF patients refractory to medical management and dependent on hospital care. Procyrion unloads the heart and perfuses the kidneys, improving HF symptoms caused by fluid overload. MethodsUsing an ovine model of chronic HF with decreased EF and an enlarged LV, the Procyrion pump was deployed into the proximal descending aorta. The animal was instrumented to observe ventricular volume and pressure, aortic pressure, renal function, myocardial oxygen extraction, and organ perfusion. Using an ovine model of chronic HF with decreased EF and an enlarged LV, the Procyrion pump was deployed into the proximal descending aorta. The animal was instrumented to observe ventricular volume and pressure, aortic pressure, renal function, myocardial oxygen extraction, and organ perfusion. ResultsThe Procyrion pump caused significant decreases in afterload and myocardial oxygen consumption as well as increases in cardiac output, ejection fraction, urine output, and glomerular filtration rate. Furthermore, the pump maintained aortic arch pressure and greatly improved myocardial oxygen supply/demand ratio. The Procyrion pump caused significant decreases in afterload and myocardial oxygen consumption as well as increases in cardiac output, ejection fraction, urine output, and glomerular filtration rate. Furthermore, the pump maintained aortic arch pressure and greatly improved myocardial oxygen supply/demand ratio. ConclusionCardiorenal HF patients are in need of treatment options to simultaneously unload the heart and perfuse the kidneys while minimizing coronary and carotid steal. Our data suggest that the Procyrion device meets these needs using an ambulatory, catheter-delivered pump. Cardiorenal HF patients are in need of treatment options to simultaneously unload the heart and perfuse the kidneys while minimizing coronary and carotid steal. Our data suggest that the Procyrion device meets these needs using an ambulatory, catheter-delivered pump.
Read full abstract